1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 13 OCTOBER 2014

Drug Delivery Insight 13 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Aesica Acquisition Augments Consort's Expansion Strategy
Industry Trend Analysis - BD Eyes Accelerated Vertical Expansion Through CareFusion Acquisition
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Brief - Sigmoid/Pendopharm Enter Deal For CyCol Commercialisation Rights In Canada
Industry Brief - to-BBB Completes Management Team And Changes Name To BBB Therapeutics
Industry Brief - Boehringer To Expand German Respimat Production
Industry Brief - Quest/Bioceltran Licensing Deal For Photodynamic Therapy Technology
Industry Brief - Sunovion To Sell Xopenex Rights To Akorn
Industry Brief - IntelGenx' Founder Named As President/CEO
Industry Brief - Unilife/Sanofi Enter Commercial Supply Agreement For Wearable Injectors
Industry Brief - Actavis Confirms Generic Butrans Patent Challenge
Industry Brief - BTG Set To Bypass Distribution Partners In Certain European Countries
Industry Brief - FDA Approves Abilify Maintena Dual-Chamber Syringe
Industry Brief - EC Approves Lilly's Humalog 200 Units/mL KwikPen
Industry Brief - Animas Vibe Insulin Pump Launched In Canada For Paediatric Market
Industry Brief - Striverdi Respimat Available In US As COPD Maintenance Treatment
Industry Brief - ESMO Endorses Yttrium-90 Radioembolisation For Non-Resectable Liver Cancer
Industry Brief - AirFluSal Forspiro Respiratory Inhaler Approved In Portugal
Industry Brief - Purdue Commercially Launches New Dosage Strength Of Butrans
Industry Trend Analysis - Embolic Protection System Innovation Milestone Critical For TAVR Success
Industry Trend Analysis - Oxford BioTherapeutics Instrumental In Several Of Big Pharma's ADC Developments
Industry Trend Analysis - GDUFA Science Priorities Underline Direction Of Generic Market
Industry Brief - Discovery Laboratories Secures US Grant To Develop KL4 Surfactant
Industry Brief - Nova Secures US Patent For Hypodermic Rehydration Injection System
Industry Brief - Positive Top-Line Results From ITCA 650 Phase III Trials Released
Industry Brief - Dosing Begins In Twirla Phase III SECURE Study
Industry Brief - Savara Raises Funds To Advance AeroVanc; Completes Phase II Trial Enrolment
Industry Brief - Pinnacle Reports European Site Initiation For Photofrin Phase III Bile Duct Cancer Trial
Industry Brief - Delcath Commences US Phase II Study Of Melphalan/HDS In HCC
Industry Brief - Aphios Secures US Patent For Difficult To Deliver/Formulate Drugs
Industry Brief - Neos Issued Key Patent Covering XR-ODT Platform Technology
Industry Trend Analysis - Teva Behind In Abuse-Deterrent Hydrocodone ER Race
Industry Brief - US PTO Inter Partes MonoSol's Review Against BDSI Patent
Industry Brief - Zogenix Submits sNDA For Modified Formulation Of Zohydro ER
Industry Brief - IntelGenx/RedHill Submit European MAA For Rizaport

Table Of Contents

Drug Delivery Insight 13 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.